Advertisement
News
Advertisement

Precision Biopsy closes $2.5M funding

Wed, 07/06/2011 - 6:35am
Mass High Tech: The Journal of New England Technology

Precision Biopsy LLC recently closed a $2.5 million round of funding to help move the commercialization phase of a novel prostate cancer detection technology forward. The new technology was developed at the University of Colorado Anschutz Medical Campus.

Precision Biopsy is a privately-held company created by Allied Minds Inc. of Quincy in 2008. The startup focuses on optical biopsy technology designed to improve the accuracy and reliability of prostate biopsies and the diagnosis of prostate cancer.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading